Local

Multiple U.S. Class Actions Target Coupang Over Data Breach, Stock Losses

Coupang faces U.S. class action lawsuits over alleged misleading disclosures tied to a major data breach and subsequent stock declines.

Christian Faith Labeled Treason in North Korea, Believers Sent to Camps

North Korea Christianity is considered treason under the Kim regime, leading to harsh punishment, while Christian groups continue outreach despite isolation.

One Year After the Eaton Fire, Altadena Still Rebuilds

One year after the Eaton Fire, Altadena residents face slow rebuilding. A Korean American family leads Eaton Fire recovery through community aid.

Korean American Church Funds $1.2 Million Traffic Light Near Site of Fatal Crash

A Korean American church paid $1.2 million to install a church-funded traffic light in Lakeview Terrace after years of speeding and safety concerns.

Faith-Based Animated Film “David” Surges to No. 2 at Box Office

The David animated film opened No. 2 in North America with $22 million, drawing attention for its box office performance and conservative influencer promotion.

Korean American Influencer’s 5-Year-Old Son Dies After 11-Day Fight With Flu

A Korean American influencer’s 5-year-old son died after an 11-day fight with the flu, as child deaths are reported this flu season.

Visiting Korea? Medical Tourism Options Are Expanding for Travelers

Medical tourism options are expanding for travelers visiting Korea, offering easier access to treatment, planning support, and verified information.

LA Descendants Finally Receive Long-Delayed Korean Independence Medal

A Korean independence medal was delivered to descendants after an LA grave project identified heirs and began reinterment preparations.

AI Cheating Hits LA Schools as Educators Scramble to Respond

AI cheating in schools surfaced after LAUSD students used Google Lens on exams, raising concerns about student dependence on artificial intelligence.

350+ Drug Prices Climb as US Pressure Fails to Slow Big Pharma

US drug price hikes affect 350+ medicines this year, led by Pfizer and GSK, despite federal government pressure to cut costs.